Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
44.69B | 45.52B | 45.86B | 40.97B | 51.12B | 53.49B | Gross Profit |
9.59B | 9.24B | 9.14B | 7.49B | 9.31B | 10.13B | EBIT |
1.44B | 956.03M | 952.95M | -149.99M | 548.78M | 782.02M | EBITDA |
1.67B | 1.45B | 1.22B | 21.88M | 784.93M | 1.14B | Net Income Common Stockholders |
1.15B | 673.08M | 648.47M | -245.66M | 326.31M | 509.31M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.33B | 10.43B | 11.64B | 13.25B | 9.04B | 8.96B | Total Assets |
51.94B | 50.55B | 46.41B | 49.91B | 46.89B | 52.61B | Total Debt |
26.27B | 18.41B | 16.90B | 21.74B | 19.67B | 23.40B | Net Debt |
18.94B | 7.97B | 5.26B | 8.49B | 10.64B | 14.51B | Total Liabilities |
37.41B | 35.23B | 31.50B | 35.40B | 31.84B | 35.69B | Stockholders Equity |
14.53B | 15.32B | 14.91B | 14.52B | 15.05B | 16.92B |
Cash Flow | Free Cash Flow | ||||
0.00 | -2.46B | 3.52B | 2.45B | 4.14B | 5.90B | Operating Cash Flow |
0.00 | -2.37B | 3.54B | 2.56B | 4.18B | 6.11B | Investing Cash Flow |
0.00 | -46.47M | -16.50M | -117.80M | 462.77M | -106.08M | Financing Cash Flow |
0.00 | 1.21B | -5.13B | 1.78B | -3.99B | -5.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥7.59B | 11.39 | 3.64% | -0.75% | 3.29% | ||
72 Outperform | ¥6.10B | 7.26 | 4.10% | -3.79% | 222.51% | ||
63 Neutral | $6.98B | 11.41 | 2.80% | 4.24% | 2.68% | -24.94% | |
59 Neutral | ¥11.27B | 47.84 | 4.80% | 0.38% | -73.76% | ||
58 Neutral | ¥4.66B | ― | 2.01% | -21.44% | 34.07% | ||
57 Neutral | ¥10.25B | 7.93 | 4.95% | 47.96% | -2.86% |